JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD

Exclusion Criteria

• •Subjects who fall under the contraindications listed in the precautions for use section of the approved labeling for Fexuclu tablets:
• •1. Subjects with hypersensitivity or a history of hypersensitivity to the investigational drug or any of its components
• •2. Subjects currently taking medications containing atazanavir, nelfinavir, or rilpivirine
• •3. Pregnant women, women who may be pregnant, or breastfeeding women
• •4. Subjects with genetic disorders such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption
• •Subjects deemed inappropriate for participation in the study at the investigator's discretion.